Synchronous hepatectomy and splenectomy vs hepatectomy for selected patients with hepatocellular carcinoma and clinically significant portal hypertension: A systematic review and meta‐analysis
Authors:
- 18 February 2019
- journal article
- review article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 119 (7) , 964-973
Abstract
This review aimed to evaluate the safety, feasibility, and effectiveness of synchronous hepatectomy and splenectomy for selected patients with hepatocellular carcinoma and clinically significant portal hypertension compared to hepatectomy alone. A systematic search in electronic databases was conducted. A total of 8 studies including 1445 patients were reviewed. While perioperative safety was satisfactory, synchronous hepatectomy and splenectomy were associated with a significant improvement of 5‐year overall survival (odds ratio = 1.81; 95% confidence interval: 1.35, 2.42; P < 0.0001).Keywords
Funding Information
- National Natural Science Foundation of China (81770566)
This publication has 38 references indexed in Scilit:
- Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patientsLiver International, 2013
- Immune Tolerance to Tumor Antigens Occurs in a Specialized Environment of the SpleenCell Reports, 2012
- Platelet Administration Via the Portal Vein Promotes Liver Regeneration in Rats After 70% HepatectomyAnnals of Surgery, 2011
- Splenectomy reduces fibrosis and preneoplastic lesions with increased triglycerides and essential fatty acids in rat liver cirrhosis induced by a choline‐deficient L‐amino acid‐defined dietHepatology Research, 2011
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLOS Medicine, 2009
- Use of hepatectomy and splenectomy to treat hepatocellular carcinoma with cirrhotic hypersplenismBritish Journal of Surgery, 2005
- Appraisal of concomitant splenectomy in liver resection for hepatocellular carcinoma in cirrhotic patients with hypersplenic thrombocytopeniaSurgery, 2004
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Splenectomy in patients with hepatocellular carcinoma and hypersplenism1Journal of the American College of Surgeons, 2000
- Regulation of tumor growth by soluble spleen factors: Effect of tumor resectionJournal of Surgical Oncology, 1987